Model-based dose-escalation methods for phase I trials, from classical CRM to more flexible Bayesian designs.
Bayesian meta-analysis tools in Stan for sparse data, hierarchical models, and weakly informative priors.
Fast Bayesian network meta-analysis with INLA, including heterogeneity and inconsistency assessment.